These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7479227

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Effect of water immersion on levels of atrial natriuretic peptide in patients with chronic renal failure].
    Zukowska-Szczechowska E, Kokot F, Grzeszczak W, Wiecek A.
    Pol Tyg Lek; ; 44(36-39):839-42. PubMed ID: 2535018
    [Abstract] [Full Text] [Related]

  • 23. Interrelationships among the renin-angiotensin system, sympathetic nervous system and atrial natriuretic peptide in end-stage renal failure.
    Nakajima S, Suzuki H, Kageyama Y, Ogata Y, Saruta T.
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):305-11. PubMed ID: 2141372
    [Abstract] [Full Text] [Related]

  • 24. [Levels of immunoreactive atrial natriuretic peptide in the blood of children on hemodialysis therapy].
    Jovanović O, Mirić-Nastić D, Popović-Rolović M, Antić-Peco A, Kostić M, Kruscić D.
    Srp Arh Celok Lek; 1992 Mar; 120(9-10):277-80. PubMed ID: 1306019
    [Abstract] [Full Text] [Related]

  • 25. Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis.
    Korzets Z, Pomeranz M, Shilo L, Pomeranze A, Levi A, Shenkman L, Berheim J.
    Adv Perit Dial; 1989 Mar; 5():20-3. PubMed ID: 2577411
    [Abstract] [Full Text] [Related]

  • 26. Neuroendocrinology of chronic renal failure and renal transplantation.
    Crum R, Fairchild R, Bronsther O, Dominic W, Ward D, Fernandez R, Brown MR.
    Transplantation; 1991 Nov; 52(5):818-23. PubMed ID: 1835195
    [Abstract] [Full Text] [Related]

  • 27. Plasma atrial natriuretic peptide, body weight and twenty-four-hour blood pressure monitoring in chronic hemodialysis patients.
    Ojanen S, Pietilä K, Pasternack A.
    Nephron; 1996 Nov; 73(2):174-8. PubMed ID: 8773340
    [Abstract] [Full Text] [Related]

  • 28. [Relationship between vasoactive substances and changes in blood pressure during hemodialysis].
    Takahashi M.
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):549-57. PubMed ID: 7474507
    [Abstract] [Full Text] [Related]

  • 29. [Elevated plasma levels and heterogeneity of human atrial natriuretic peptide in patients with progressive chronic renal failure].
    Predel HG, Kipnowski J, Bäcker A, Stelkens H, Jürgens U, Düsing R, Kramer HJ.
    Z Kardiol; 1988 Oct; 77 Suppl 2():65-71. PubMed ID: 2970177
    [Abstract] [Full Text] [Related]

  • 30. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure.
    Kurnik BR, Weisberg LS, Cuttler IM, Kurnik PB.
    J Lab Clin Med; 1990 Jul; 116(1):27-36. PubMed ID: 2142949
    [Abstract] [Full Text] [Related]

  • 31. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F.
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [Abstract] [Full Text] [Related]

  • 32. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
    Pedersen EB, Bacevicius E, Bech JN, Solling K, Pedersen HB.
    Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
    [Abstract] [Full Text] [Related]

  • 33. Atrial natriuretic peptide and parathyroid hormone (1-84) in relation to noradrenaline induced changes in blood pressure in uraemic and healthy subjects.
    Jespersen B, Jensen JD, Brock A, Pedersen EB.
    Scand J Urol Nephrol; 1992 Apr; 26(3):269-74. PubMed ID: 1332188
    [Abstract] [Full Text] [Related]

  • 34. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E, Moczulski D, Grzeszczak W, Gosek K, Augustyn M, Staszewicz P.
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [Abstract] [Full Text] [Related]

  • 35. [Changes in levels of atrial natriuretic peptide (ANP) in patients with chronic renal failure during physical exertion].
    Burak W, Grzeszczak W, Zukowska-Szczechowska E.
    Pol Arch Med Wewn; 1994 Jul; 92(1):35-40. PubMed ID: 7971475
    [Abstract] [Full Text] [Related]

  • 36. [Clinical relevance of the determination of plasma atrial natriuretic peptide in children with chronic renal failure].
    Rascher W, Bald M, Kröner F, Tulassay T, Müller-Wiefel DE.
    Z Kardiol; 1988 Jul; 77 Suppl 2():61-4. PubMed ID: 2970176
    [Abstract] [Full Text] [Related]

  • 37. Haemodialysis arteriovenous access--a prospective haemodynamic evaluation.
    Ori Y, Korzets A, Katz M, Perek Y, Zahavi I, Gafter U.
    Nephrol Dial Transplant; 1996 Jan; 11(1):94-7. PubMed ID: 8649659
    [Abstract] [Full Text] [Related]

  • 38. Plasma concentration of human atrial natriuretic polypeptide in patients with impaired renal function.
    Yamamoto Y, Higa T, Kitamura K, Tanaka K, Kangawa K, Matsuo H.
    Clin Nephrol; 1987 Feb; 27(2):84-6. PubMed ID: 2951044
    [Abstract] [Full Text] [Related]

  • 39. Central blood volume, atrial natriuretic peptide and intermittent hemodialysis.
    Wallin CJ, Rossi P, Jacobson SH, Leksell LG.
    Scand J Urol Nephrol; 2004 Feb; 38(1):78-84. PubMed ID: 15204432
    [Abstract] [Full Text] [Related]

  • 40. Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure.
    Anderson JV, Raine AE, Proudler A, Bloom SR.
    J Endocrinol; 1986 Aug; 110(2):193-6. PubMed ID: 2943848
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.